Annual CFF
$14.78 M
+$5.12 M+53.01%
30 November 2023
Summary:
Theratechnologies annual cash flow from financing activities is currently $14.78 million, with the most recent change of +$5.12 million (+53.01%) on 30 November 2023. During the last 3 years, it has fallen by -$23.09 million (-60.98%). THTX annual CFF is now -74.10% below its all-time high of $57.05 million, reached on 30 November 2007.THTX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$1.87 M
-$1.23 M-192.33%
31 August 2024
Summary:
Theratechnologies quarterly cash flow from financing activities is currently -$1.87 million, with the most recent change of -$1.23 million (-192.33%) on 31 August 2024. Over the past year, it has dropped by -$24.96 million (-108.09%). THTX quarterly CFF is now -103.67% below its all-time high of $50.93 million, reached on 31 August 2018.THTX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$20.31 M
+$6.05 M+42.38%
31 August 2024
Summary:
Theratechnologies TTM cash flow from financing activities is currently $20.31 million, with the most recent change of +$6.05 million (+42.38%) on 31 August 2024. Over the past year, it has increased by +$5.54 million (+37.47%). THTX TTM CFF is now -68.92% below its all-time high of $65.34 million, reached on 28 February 2007.THTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
THTX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -108.1% | +37.5% |
| 3 y3 years | -61.0% | +14.5% | -46.4% |
| 5 y5 years | +317.1% | -100.0% | +398.4% |
THTX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -61.0% | +304.4% | -108.1% | +76.4% | -49.1% | +430.1% |
| 5 y | 5 years | -68.9% | +304.4% | -104.5% | +76.4% | -49.1% | +381.0% |
| alltime | all time | -74.1% | +304.4% | -103.7% | +76.4% | -68.9% | +381.0% |
Theratechnologies Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Aug 2024 | - | -$1.87 M(+192.3%) | $20.31 M(+42.4%) |
| May 2024 | - | -$639.00 K(+132.4%) | $14.27 M(-2.7%) |
| Feb 2024 | - | -$275.00 K(-101.2%) | $14.66 M(-0.8%) |
| Nov 2023 | $14.78 M(+53.0%) | $23.09 M(-391.8%) | $14.78 M(-340.1%) |
| Aug 2023 | - | -$7.91 M(+3170.2%) | -$6.15 M(-163.0%) |
| May 2023 | - | -$242.00 K(+49.4%) | $9.76 M(-0.6%) |
| Feb 2023 | - | -$162.00 K(-107.5%) | $9.82 M(+1.7%) |
| Nov 2022 | $9.66 M(-74.5%) | $2.17 M(-72.9%) | $9.66 M(+81.9%) |
| Aug 2022 | - | $8.00 M(-4448.4%) | $5.31 M(-226.7%) |
| May 2022 | - | -$184.00 K(-43.6%) | -$4.19 M(+15.4%) |
| Feb 2022 | - | -$326.00 K(-85.1%) | -$3.63 M(-109.6%) |
| Nov 2021 | $37.86 M(-623.8%) | -$2.18 M(+46.1%) | $37.86 M(-5.1%) |
| Aug 2021 | - | -$1.50 M(-499.7%) | $39.90 M(+10.5%) |
| May 2021 | - | $374.00 K(-99.1%) | $36.10 M(+1.0%) |
| Feb 2021 | - | $41.17 M(<-9900.0%) | $35.73 M(-594.3%) |
| Nov 2020 | -$7.23 M(+6.2%) | -$151.00 K(-97.1%) | -$7.23 M(+2.1%) |
| Aug 2020 | - | -$5.29 M(<-9900.0%) | -$7.08 M(+2.0%) |
| May 2020 | - | $10.00 K(-100.6%) | -$6.94 M(+0.9%) |
| Feb 2020 | - | -$1.79 M(<-9900.0%) | -$6.88 M(+1.0%) |
| Nov 2019 | -$6.81 M(-114.3%) | $0.00(-100.0%) | -$6.81 M(+2.7%) |
| Aug 2019 | - | -$5.15 M(-7461.4%) | -$6.63 M(-113.4%) |
| May 2019 | - | $70.00 K(-104.1%) | $49.46 M(+8.2%) |
| Feb 2019 | - | -$1.72 M(-1068.5%) | $45.70 M(-3.7%) |
| Nov 2018 | $47.46 M(+245.2%) | $178.00 K(-99.7%) | $47.46 M(+0.8%) |
| Aug 2018 | - | $50.93 M(-1482.9%) | $47.10 M(-4619.9%) |
| May 2018 | - | -$3.68 M(<-9900.0%) | -$1.04 M(-150.0%) |
| Feb 2018 | - | $29.00 K(-115.9%) | $2.09 M(-84.8%) |
| Nov 2017 | $13.75 M(-480.5%) | -$182.30 K(-106.5%) | $13.75 M(-2.7%) |
| Aug 2017 | - | $2.79 M(-602.9%) | $14.14 M(+24.5%) |
| May 2017 | - | -$555.60 K(-104.8%) | $11.36 M(+40.3%) |
| Feb 2017 | - | $11.69 M(+5578.9%) | $8.10 M(-324.1%) |
| Nov 2016 | -$3.61 M(-206.8%) | $205.90 K(+1281.9%) | -$3.61 M(-42.1%) |
| Aug 2016 | - | $14.90 K(-100.4%) | -$6.25 M(<-9900.0%) |
| May 2016 | - | -$3.82 M(>+9900.0%) | $47.90 K(-98.6%) |
| Feb 2016 | - | -$18.40 K(-99.2%) | $3.37 M(-0.5%) |
| Nov 2015 | $3.38 M(>+9900.0%) | -$2.43 M(-138.5%) | $3.38 M(-41.8%) |
| Aug 2015 | - | $6.31 M(-1366.5%) | $5.81 M(-1266.5%) |
| May 2015 | - | -$498.10 K(<-9900.0%) | -$498.10 K(<-9900.0%) |
| Feb 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2014 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2014 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Nov 2012 | $244.60 K(-64.0%) | -$100.00(-101.1%) | $244.60 K(+3.2%) |
| Aug 2012 | - | $8900.00(-80.5%) | $237.10 K(-1.2%) |
| May 2012 | - | $45.70 K(-76.0%) | $240.00 K(-72.2%) |
| Feb 2012 | - | $190.10 K(-2601.3%) | $864.80 K(+27.2%) |
| Nov 2011 | $679.80 K(+371.4%) | -$7600.00(-164.4%) | $679.80 K(-2.4%) |
| Aug 2011 | - | $11.80 K(-98.2%) | $696.70 K(-3.1%) |
| May 2011 | - | $670.50 K(>+9900.0%) | $719.30 K(+536.0%) |
| Feb 2011 | - | $5100.00(-45.2%) | $113.10 K(-21.6%) |
| Nov 2010 | $144.20 K | $9300.00(-73.0%) | $144.20 K(-73.2%) |
| Aug 2010 | - | $34.40 K(-46.5%) | $538.40 K(+16.9%) |
| May 2010 | - | $64.30 K(+77.6%) | $460.70 K(-72.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Feb 2010 | - | $36.20 K(-91.0%) | $1.68 M(-82.1%) |
| Nov 2009 | $9.40 M(-58.8%) | $403.50 K(-1031.9%) | $9.40 M(+79.8%) |
| Aug 2009 | - | -$43.30 K(-103.4%) | $5.23 M(+55.7%) |
| May 2009 | - | $1.28 M(-83.4%) | $3.36 M(+119.4%) |
| Feb 2009 | - | $7.76 M(-305.7%) | $1.53 M(-93.3%) |
| Nov 2008 | $22.84 M(-60.0%) | -$3.77 M(+97.0%) | $22.84 M(-23.4%) |
| Aug 2008 | - | -$1.91 M(+252.5%) | $29.82 M(-8.2%) |
| May 2008 | - | -$542.80 K(-101.9%) | $32.47 M(-16.1%) |
| Feb 2008 | - | $29.07 M(+806.1%) | $38.68 M(-32.2%) |
| Nov 2007 | $57.05 M(+218.7%) | $3.21 M(+336.6%) | $57.05 M(+7.1%) |
| Aug 2007 | - | $734.70 K(-87.0%) | $53.25 M(+1.8%) |
| May 2007 | - | $5.67 M(-88.1%) | $52.32 M(-19.9%) |
| Feb 2007 | - | $47.44 M(-8102.8%) | $65.34 M(+265.0%) |
| Nov 2006 | $17.90 M(>+9900.0%) | -$592.80 K(+202.9%) | $17.90 M(-3.2%) |
| Aug 2006 | - | -$195.70 K(-101.0%) | $18.50 M(-1.1%) |
| May 2006 | - | $18.69 M(>+9900.0%) | $18.70 M(>+9900.0%) |
| Feb 2006 | - | $0.00(-100.0%) | $55.60 K(0.0%) |
| Nov 2005 | $55.70 K(-99.5%) | $5100.00(+88.9%) | $55.60 K(-58.8%) |
| Aug 2005 | - | $2700.00(-94.4%) | $135.00 K(-73.8%) |
| May 2005 | - | $47.80 K(>+9900.0%) | $515.20 K(+203.2%) |
| Feb 2005 | - | $0.00(-100.0%) | $169.90 K(-98.5%) |
| Nov 2004 | $11.18 M(+2454.7%) | $84.50 K(-77.9%) | $11.18 M(-1.5%) |
| Aug 2004 | - | $382.90 K(-228.7%) | $11.35 M(+2.6%) |
| May 2004 | - | -$297.50 K(-102.7%) | $11.06 M(-3.2%) |
| Feb 2004 | - | $11.01 M(+4160.6%) | $11.43 M(+2512.5%) |
| Nov 2003 | $437.60 K(-97.6%) | $258.40 K(+179.7%) | $437.50 K(+111.4%) |
| Aug 2003 | - | $92.40 K(+33.5%) | $207.00 K(-182.3%) |
| May 2003 | - | $69.20 K(+295.4%) | -$251.60 K(-137.2%) |
| Feb 2003 | - | $17.50 K(-37.3%) | $677.20 K(-96.3%) |
| Nov 2002 | $18.38 M(-52.7%) | $27.90 K(-107.6%) | $18.38 M(-0.4%) |
| Aug 2002 | - | -$366.20 K(-136.7%) | $18.45 M(-67.5%) |
| May 2002 | - | $998.00 K(-94.4%) | $56.79 M(+0.7%) |
| Feb 2002 | - | $17.72 M(>+9900.0%) | $56.41 M(+45.2%) |
| Nov 2001 | $38.84 M(+14.1%) | $99.20 K(-99.7%) | $38.84 M(-12.8%) |
| Aug 2001 | - | $37.97 M(+6014.7%) | $44.55 M(+340.3%) |
| May 2001 | - | $621.00 K(+318.5%) | $10.12 M(-68.4%) |
| Feb 2001 | - | $148.40 K(-97.4%) | $31.99 M(-6.0%) |
| Nov 2000 | $34.04 M(+288.6%) | $5.81 M(+64.2%) | $34.04 M(+20.0%) |
| Aug 2000 | - | $3.54 M(-84.3%) | $28.36 M(-3.9%) |
| May 2000 | - | $22.49 M(+919.7%) | $29.52 M(+169.2%) |
| Feb 2000 | - | $2.21 M(+1609.5%) | $10.97 M(+25.2%) |
| Nov 1999 | $8.76 M(+11.2%) | $129.00 K(-97.3%) | $8.76 M(-1.0%) |
| Aug 1999 | - | $4.70 M(+19.4%) | $8.85 M(+92.3%) |
| May 1999 | - | $3.93 M(>+9900.0%) | $4.60 M(-41.6%) |
| Feb 1999 | - | $0.00(-100.0%) | $7.88 M(0.0%) |
| Nov 1998 | $7.88 M(-5706.8%) | $221.30 K(-50.6%) | $7.88 M(+4.8%) |
| Aug 1998 | - | $447.70 K(-93.8%) | $7.52 M(+6.3%) |
| May 1998 | - | $7.21 M(>+9900.0%) | $7.07 M(-5130.7%) |
| Feb 1998 | - | $0.00(-100.0%) | -$140.50 K(0.0%) |
| Nov 1997 | -$140.50 K(-102.4%) | -$140.50 K(<-9900.0%) | -$140.50 K(<-9900.0%) |
| Aug 1997 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 1997 | - | $0.00(0.0%) | $0.00(0.0%) |
| Feb 1997 | - | $0.00 | $0.00 |
| Nov 1996 | $5.79 M | - | - |
FAQ
- What is Theratechnologies annual cash flow from financing activities?
- What is the all time high annual CFF for Theratechnologies?
- What is Theratechnologies quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Theratechnologies?
- What is Theratechnologies quarterly CFF year-on-year change?
- What is Theratechnologies TTM cash flow from financing activities?
- What is the all time high TTM CFF for Theratechnologies?
- What is Theratechnologies TTM CFF year-on-year change?
What is Theratechnologies annual cash flow from financing activities?
The current annual CFF of THTX is $14.78 M
What is the all time high annual CFF for Theratechnologies?
Theratechnologies all-time high annual cash flow from financing activities is $57.05 M
What is Theratechnologies quarterly cash flow from financing activities?
The current quarterly CFF of THTX is -$1.87 M
What is the all time high quarterly CFF for Theratechnologies?
Theratechnologies all-time high quarterly cash flow from financing activities is $50.93 M
What is Theratechnologies quarterly CFF year-on-year change?
Over the past year, THTX quarterly cash flow from financing activities has changed by -$24.96 M (-108.09%)
What is Theratechnologies TTM cash flow from financing activities?
The current TTM CFF of THTX is $20.31 M
What is the all time high TTM CFF for Theratechnologies?
Theratechnologies all-time high TTM cash flow from financing activities is $65.34 M
What is Theratechnologies TTM CFF year-on-year change?
Over the past year, THTX TTM cash flow from financing activities has changed by +$5.54 M (+37.47%)